Literature DB >> 35688196

Critical role of Hyssop plant in the possible transmission of SARS-CoV-2 in contaminated human Feces and its implications for the prevention of the virus spread in sewage.

Sasan Zahmatkesh1, Jiří Jaromír Klemeš2, Awais Bokhari3, Chongqing Wang4, Mika Sillanpaa5, Mudassir Hasan6, Kassian T T Amesho7.   

Abstract

The significant issue affecting wastewater treatment is human faeces containing SARS-CoV-2. SARS-CoV-2, as a novel coronavirus, has expanded globally. While the current focus on the COVID-19 epidemic is rightly on preventing direct transmission, the risk of secondary transmission via wastewater should not be overlooked. Many researchers have demonstrated various methods and tools for preventing and declining this virus in wastewater treatment, especially for SARS-CoV-2 in human faeces. This research reports two people tested for 30 d, with written consent, at Mosa-Ebne-Jafar Hospital of Quchan, Iran, from September 1st to October 9th, 2021. The two people's conditions are the same. The Hyssop plant was used, which boosts the immune system's effectiveness and limonene, rosemary, caffeic acids and flavonoids, all biologically active compounds in this plant, cause improved breathing problems, colds, and especially for SARS-CoV-2. As a result, utilising the Hyssop plant can help in reducing SARS-CoV-2 in faeces. This plant's antioxidant properties effectively reduce SARS-CoV-2 in faeces by 30%; nevertheless, depending on the patient's condition. This plant is also beneficial for respiratory and digestive health.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Faeces; Hyssop plant; Respiratory and digestive; SARS-CoV-2; Wastewater treatment

Mesh:

Substances:

Year:  2022        PMID: 35688196      PMCID: PMC9173688          DOI: 10.1016/j.chemosphere.2022.135247

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   8.943


Introduction

As of January 19, 2019, the World Health Organisation (WHO) has officially declared Coronavirus disease 2019 (COVID-19) (Lai et al., 2020), causing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pal et al., 2020). The Coronaviridae family includes SARS-CoV-2, an enveloped virus containing a single-stranded RNA genome (Wang et al., 2020a). Coronaviridae can cause various symptoms (Roussel et al., 2021), including common colds (Wang et al., 2021) and acute respiratory distress syndrome (Xia et al., 2021). There are two main routes by which SARS-CoV-2 is transmitted (Pavilonis et al., 2021): inhalation of aerosol/droplet (Port et al., 2021) and direct contact (Ng et al., 2021), but currently, evidence suggests that viral RNA can be found in wastewater. The faeces have recently been found to contain this virus (Chen et al., 2020). It can also be found in municipal sewage, spreading it to further areas from inadequately treated effluents; in this way, wastewater monitoring can be effectively implemented (Teymoorian et al., 2021). Wastewater-based epidemiology (WBE) effectively calculates the prevalence, genetic diversity, and geographical distribution of viruses in a given community (Wurtzer et al., 2021). In order to build a system for early warning and intervention, the WBE will require the development of a quick analytical approach for the on-site identification of viruses at the wastewater collection point (Hemalatha et al., 2021). An entire region's faeces can be analysed with the help of wastewater systems (Prado et al., 2021). Many viral infections do not cause symptoms and clinical infections are often misdiagnosed, this method makes it possible to monitor an outbreak of viral infections even if they are not evident based on clinical surveillance. This is highlighted by the fact that many viral infections are asymptomatic. (LaTurner et al., 2021). In addition to the viruses shed via faeces, these limitations restrict other viruses such as norovirus, sapovirus, enterovirus, rotavirus, and hepatitis (Li et al., 2021). The wastewater surveillance could help measure the spread of disease worldwide, despite limited clinical diagnosis resources and inaccessible or infeasible reporting systems, such as in developing countries (Albastaki et al., 2021). Last but not least, a wastewater surveillance program for SARS-CoV-2 could be beneficial because a wastewater surveillance program would provide up-to-date information about infection trends without affecting availability (Zahedi et al., 2021). In order to implement and interpret this new surveillance tool, practical and technological challenges must be addressed (Hoffmann and Alsing, 2021). An essential aspect of determining the level of this virus is to have an accurate method of measuring it in complicated wastewater matrixes requiring specialised equipment and expertise (Wu et al., 2021). The regularly updated data indicate that SARS-CoV-2 is present in faeces at about 100 ± 10 nm (Elsamadony et al., 2021). SARS-CoV-2 was detected in wastewater samples containing a concentration of up to 200 mL of raw wastewater (Qiu et al., 2021). In order to decrease and prevent SARS-CoV-2 transmissions (Brahim Belhaouari et al., 2021), the water concentration volumes should impact virus detection; 100 mL of untreated wastewater samples are sufficient to detect enteric viruses (Serra-Compte et al., 2021). A primary method for detecting SARS-CoV-2 is RT-qPCR or (nested) RT-PCR. Assays for SARS-CoV-2 that use RT-qPCR and nested RT-PCR are currently available (Zahmatkesh and Sillanpää, 2022). Evidence shows that viral infections (SARS-CoV and SARS-CoV-2) exhibit many similar pathophysiological processes, including direct lung injury, cytokine storms, immunodeficiency, and other organ harm. SARS in 2003 (an outbreak caused by SARS-CoV) led to the study of many plants (as well as herbal teas and natural compounds) as potential treatments and preventions for Coronavirus infection (Ren et al., 2020). On the basis of the similarities between SARS-CoV and SARS-CoV-2 in epidemiology, genetics, and pathogenic processes, edible and medicinal plants may prove to be beneficial in the management of COVID-19 (Zahmatkesh et al., 2022). On the basis of our existing knowledge of the pathogen, a number of data-driven methods and computational chemical biology techniques (including molecular docking) have been used to screen prospective natural drugs for the management of COVID-19. In a relatively short amount of time, quite a few screenings on a massive scale have been carried out. There have been a lot of discoveries made on natural herbal medicines and dietary bioactive substances (Lin et al., 2021). In view of the aforementioned new method of preventing SARS-CoV-2 from spreading into sewage, this is a promising new method for preventing it from spreading into faeces. The present work aims to investigate the impact of the Hyssop plant, a highly nutritious plant with various health-preserving secondary metabolites, as a new method for removing SARS-CoV-2 in human faeces. A variety of studies have been conducted on the chemical and biological effects of leaf extracts of Hyssopus officinalis. Researchers have studied its antimicrobial, antioxidant, antifungal, insecticidal, and antiviral properties. Pinocamphone, isopinocamphone, and β-pinene, have been associated with the antibacterial and antifungal properties of Hyssop. Several high-molecular compounds in the plant are thought to explain its antiviral activity, including caffeic acid and tannins. This study will lead to a significant advancement in the development of a new medicine that targets Coronavirus removal in human faeces and prevents the spread from wastewater while remaining a sustainable and effective process.

Materials and methods

Study design

The enrolled patients with SARS-CoV-2 were admitted to Mosa-Ebne-Jafar Hospital of Quchan, Iran, from September 1 to October 9, 2021 (Fig. S1). All enrolled patients provided written consent. This study was two people testing, and the characteristics of both people were the same; following that, for 30 d, the two patients were tested daily. Two of the participants had pharyngeal swab specimens that tested positive for SARS-CoV-2 RNA when they were analysed using real-time reverse transcription-polymerase chain reaction (RT-PCR). Patients who did not have RT-PCR test findings that were negative for viral RNA in their pharyngeal swabs were ruled out of the study. Fig. 1. illustrates the bibliometric analysis mapping created from the Web of Science core collection for the network visualisation of the terms associated with the spread of SARS-CoV-2, which can be transmitted directly from one person to another, or by contact with water, food, or surfaces. This analysis was compiled with the application of VOSviewer software.
Fig. 1

Bibliometric mapping of a network visualisation of SARS-CoV-2 in wastewater treatment.

Bibliometric mapping of a network visualisation of SARS-CoV-2 in wastewater treatment.

Laboratory examination

Every day, the stool samples from two patients were collected multiple times during the hospitalisation and recovery period, especially during the consumption hyssop plant. RT-PCR was used to detect the presence of SARS-CoV-2 RNA. Mosa-Ebne-Jafar Hospital's clinical laboratory confirmed the presence of SARS-CoV-2 RNA. The RT-PCR test was carried out according to the WHO protocol. The safety protocols and precautions from the health ministry have been advised researchers to be exposed to near only two patients for research data collection. The samples collections were taken under proper SOP's under the supervision of medical staff. The RT-qPCR kits were used to detect SARS-CoV-2 RNA from Changsha, China, and Shanghai, China. They also used probes and primers to determine the quantitative expression of gene N. For the quantitative analysis. They plotted the standard curve based on different dilutions of in vitro transcription RNA (N gene). According to the manufacturer, the assay targets parts of the SARS-CoV-2 genome. The positive control kit, an internal standard gene fragment (ORF1ab, N gene), and the negative control, namely normal saline, were used for both positive and negative controls.

Hyssop plants

Hyssop plant is a typical xerophyte that grows well in drought-prone conditions. Hyssop is used in food flavouring as well as sauce formulation despite its bitter taste. Hyssop has a long history of usage as a remedy for coughs, as well as antispasmodic, stomachic, and antifungal properties. According to a study that looked at both the chemical and biological features of the plant, the primary components of hyssop were discovered to be polyphenolic compounds and essential oils. The Hyssop essential oil and extracts exhibit antimicrobial activity, both antioxidant and antifungal, as well as insecticidal and antiviral properties, as indicated in Fig. 2 . Finally, using this plant for removing SARS-CoV-2 is effective.
Fig. 2

Picture and chemical structure of (a) a main antioxidant component of (b) Hyssop.

Picture and chemical structure of (a) a main antioxidant component of (b) Hyssop.

Hyssop plant application methodology

There are four structural proteins in the mature SARS-CoV-2 particle, namely envelope (E), membrane (M), nucleocapsid (N), and spike (S). S protein is important for antibody-based detection since the surface of the virion exposes the receptor-binding domain (RBD) to the immune system. Thus, antiviral hyssop plants reduce the viral replication cycle and, thus, prolong the time that the immune system has to respond to an infection. Proteins from hyssop plants can act as antivirals, such as carbohydrate-binding proteins (lectins). In addition to binding and inactivating a variety of viruses, lectins also inhibit the production of glycan structures on the surface of the viruses. Finally, the angiotensin-converting enzyme 2 (ACE2) from Hyssop plants can neutralize SARS-CoV-2 because it is fused with human IgG1. Thus, this protein can be used as a potential therapeutic for COVID-19, as indicated in Fig. 3 .
Fig. 3

The potential effectiveness of Hyssop plant candidates against COVID-19.

The potential effectiveness of Hyssop plant candidates against COVID-19.

Results and discussion

Between September 1 to October 9, 2021, two COVID-19 patients admitted to Mosa-Ebne-Jafar Hospital were tested. The median age was 55; both were men, and patients had a smoking history and the most prevalent symptoms were fever, dry cough, weariness, and lethargy.. In patients with SARS-CoV-2, faeces showed a 40% positive result. The patients' stool specimens were collected multiple times during their hospitalisation. For the first time, one plant test on Human faeces contaminated with SARS-CoV-2; including utilising Hyssop plants; which is to prevent Corona reduction in Corona patient faeces, as well as prevent it from spreading in the sewage; moreover, antiviral, antifungal, antimicrobial, antioxidant, and insecticidal properties Hyssop have been found to protect against SARS-CoV-2. Many compounds found in Hyssop are thought to contribute to its antibacterial and antifungal properties, including pinocamphone, isopinocamphone, and β-pinene. The plant has three phytochemicals responsible for the antiviral properties: caffeine, tannins, and an unidentified high-molecular compound. Besides, in this test, two people were tested based on their usage of the Hyssop plant over 30 d; however, one person uses it three times a day, while the other does not in Fig. 4 .
Fig. 4

Effect of Hyssop on faeces of two patients.

Effect of Hyssop on faeces of two patients. By drinking Hyssop three times a day, it was shown that this plant could decrease Corona in the stool after 10 d. There are a variety of bioactive compounds in the stem of this plant, including Llimonene, rosemary, caffeic acid, flavonoids, and merobins. Hyssop extracts and essential oil (E.O.) have been studied for their medicinal properties as well as their antiviral and antibacterial properties; moreover, the E.O. of Hyssop is antiseptic, antimicrobial, antiviral (especially against HIV), antitumor, antispasmodic, and antioxidant; it also improved the lung function of the patient (Charles, 2012). Hyssop is commonly used for medicinal, aromatic, and culinary purposes. The advantage of this plant is that Xanthophyll, which is found in the herb, contains fat, sugar, choline, tannins, carotene, and volatile oil; following that, Hyssop is used for many digestive and intestinal ailments, such as stomach pain, gas, colic, and a loss of appetite. It has been used for coughs, colds, respiratory infections, sore throats, and asthma. Excessive consumption of Hyssop can cause harm and side effects: 1) Blood pressure is increased by this plant, so people with high blood pressure should avoid it. 2) Excessive consumption may cause seizures. 3) Excessive consumption of Hyssop is harmful to the liver (Jangi et al., 2021). In this research, SARS-CoV-2 was detected in specimens of two patients for the decline in SARS-CoV-2 in faeces humans and prevention of faeces in sewage; notably, due to the fact that these two people (out of 500 people hospitalised due to SARS-CoV-2) were chosen because this plant was, for the first time, tested on people (Flow Chart1).
Flow Chart.1

A new way to detect SARS-CoV-2 in human faeces.

This study revealed that stool samples from laboratory-confirmed COVID-19 patients tested positive for SARS-CoV-2 RNA; neither symptoms of gastrointestinal illness nor severity of illness was associated with this finding. Upon testing two persons, the person who consumed the plant was found to be a negative test after 25 d based on cyclic and oral PCR; however, a stool test still showed positive results. Our study results pointed out that testing SARS-CoV-2RNA in faeces may be useful for diagnosing the infection and that considering SARS-CoV-2 transmission via the faecal-oral route should be given serious consideration. As shown in Fig. 5 , recent research conducted in a variety of countries has demonstrated that SARS-CoV-2 RNA can be identified in stool samples taken from COVID-19 patients. RNA from SARS-CoV was detected in gastrointestinal tissue samples taken endoscopically from a COVID-19 patient. An abundant amount of the Angiotensin-converting enzyme 2 (ACE2), which plays a role in the cellular entry of SARS-CoV-2, was found in the epithelia of a SARS-CoV-2 patient's gastric, duodenal, and rectal linings. This finding was made possible by the fact that ACE2 is highly expressed in these tissues. The S1 domain of SARS-CoV-2 is responsible for the binding of the virus to the cellular receptor ACE2 on host cells. As soon as the virus entered the cell, the cytoplasm was able to produce viral-specific RNA and proteins, which led to the formation of additional virions that were then released into the gastrointestinal tract. Xiao et al. (2020) identified infectious SARS-CoV-2 in stool, indicating that infectious virions were released into the gastrointestinal tract. Human faeces contain SARS-CoV-2, which is a significant problem these days; however, using Hyssop showed many antioxidants in this plant that are effective for respiratory, digestive, and immune system health. The SARS-CoV-2 in the stool was reduced by 30% by consuming this plant.
Fig. 5

Countries that confirmed that SARS-CoV-2 exists in the human faeces.

Countries that confirmed that SARS-CoV-2 exists in the human faeces. A new way to detect SARS-CoV-2 in human faeces. According to (Chen et al., 2020)., SARS-CoV-2 RNA was found in oral swabs, anal swabs, and blood samples; however, at a later stage of infection, anal swabs were more commonly positive than oral swabs. Although respiratory samples turned negative (Li et al., 2020), was reported that a stool sample from a COVID-19 patient remained positive for 33 consecutive days. As a result of the fact that viral replication in the gastrointestinal tract may be different from that in the respiratory tract, it is possible that viruses can be transmitted from the gastrointestinal tract to the oral cavity even after the respiratory tract has cleared viral particles. This may even be the case when the respiratory tract has eliminated all viral particles. It is unethical to release a patient only on the basis of negative results from an RT-PCR test for viral RNA that was performed using pharyngeal swabs as samples. The detection of viral RNA in COVID-19 patients' anal swabs or stool samples should be performed routinely during hospitalisation and recovery until the patient has tested negative for the viral RNA in faeces. This should continue until the patient has tested negative for the viral RNA in faeces (Table 1 ).
Table 1

Comparison of the presented work with other studies in the literature.

SARS-CoV-2 in Human Faeces(%)Treatment for SARS-CoV-2 in human faecesReference
29Not any way to declineWang et al. (2020b)
47.7Not any way to declineLin et al., (2020)
53.4Not any way to declineXiao et al., (2020)
80Not any way to declineXu et al., (2020)
55Not any way to declineWu et al., (2020)
15.3Not any way to declineCheung et al., (2020)
48.1Not any way to declineCheung et al., (2020)
40%Hyssop plants can decline human faeces containing SARS-CoV-2This paper
Comparison of the presented work with other studies in the literature. In terms of wastewater, correct wastewater management must necessarily begin with the sampling. High levels of viruses may be found in hospital and isolation centre wastewater and domestic wastewater from areas of contamination, which require special attention. Nevertheless, sewage systems should be monitored for leaks to prevent disease and contamination of the water supply. The typical secondary activated sludge treatment is a popular biological treatment method for eliminating pathogens because of the combined effects of wastewater aeration, biological activity of biomass, and secondary sedimentation. Inactivation of viruses can be aided by a variety of circumstances, including the length of time spent in treatment tanks and exposure to sunshine. This final step, disinfection, is essential in preventing the growth of viruses. Using secondary treatments followed by disinfection, WWTPs have proved to be effective. Although, the disinfection process is not available at all WWTPs due to differences in population equivalent (P.E.). Despite this, in light of SARS-CoV-2's high susceptibility to disinfection and to prevent the virus from spreading, it might be sensible to apply a disinfection treatment for all WWTPs and small WWTPs only during epidemic outbreaks.

Conclusion

The prevention of direct transmission of SARS-CoV-2 and the treatment of persons who have been infected are the primary focuses of the medical and public health professionals who are working on this outbreak. The secondary transmission is not something that should be disregarded. In the event that this does not occur, secondary transmission has the potential to put at risk the gains that have been so painstakingly achieved via the use of existing transmission control mechanisms and may even contribute to the reemergence of COVID-19. During the SAR-CoV-2 pandemic, many research projects were conducted in water and wastewater, to remove human faeces from sewage with various technological and methodological means. Test results indicate that after 10 d of consuming this plant, the stool of the person who consumed this plant reached almost 35%, and finally, at the end of the 30th d, the stool reached 10%. Due to its antioxidant properties, this plant reduced the SAR-CoV-2 levels in the stool and improved the patient's acute respiratory. These results in this study could be of particular importance for developing countries, as they have suffered from comparatively underprivileged public sanitation environments, which might contribute to the rapid upsurge in SARS-CoV-2 infection. The results in this study can be of wide-ranging interest and applied somewhere else. This study can provide a new solution that can control the spread of SARS-CoV-2 via wastewater, particularly during the global pandemic. This investigation will lead to important progress in developing a new medicine that targets Coronavirus removal in human faeces and prevents the spread from wastewater while remaining a sustainable and effective process.

Credit author statement

Sasan Zahmatkesh: Collected the research articles, analysed, testing, and prepared the first original draft, screened, Software, and analysed the key findings; Jiří Jaromír Klemeš: Supervision, Writing-review & editing, Validation, Funding; Kassian T.T. Amesho: Writing-reviewing, editing. Awais Bokhari & Mudassir Hasan: Writing - review & editing, Chongqing Wang: Writing - original draft, Mika Sillanpää: Writing - review & editing, Supervisor,

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  31 in total

1.  Surveillance of SARS-CoV-2 spread using wastewater-based epidemiology: Comprehensive study.

Authors:  Manupati Hemalatha; Uday Kiran; Santosh Kumar Kuncha; Harishankar Kopperi; C G Gokulan; S Venkata Mohan; Rakesh K Mishra
Journal:  Sci Total Environ       Date:  2021-01-06       Impact factor: 7.963

2.  Estimating aerosol transmission risk of SARS-CoV-2 in New York City public schools during reopening.

Authors:  Brian Pavilonis; A Michael Ierardi; Leon Levine; Franklin Mirer; Elizabeth A Kelvin
Journal:  Environ Res       Date:  2021-01-26       Impact factor: 6.498

3.  Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology.

Authors:  Zachary W LaTurner; David M Zong; Prashant Kalvapalle; Kiara Reyes Gamas; Austen Terwilliger; Tessa Crosby; Priyanka Ali; Vasanthi Avadhanula; Haroldo Hernandez Santos; Kyle Weesner; Loren Hopkins; Pedro A Piedra; Anthony W Maresso; Lauren B Stadler
Journal:  Water Res       Date:  2021-03-15       Impact factor: 11.236

4.  Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.

Authors:  Mikael Roussel; Juliette Ferrant; Florian Reizine; Simon Le Gallou; Joelle Dulong; Sarah Carl; Matheiu Lesouhaitier; Murielle Gregoire; Nadège Bescher; Clotilde Verdy; Maelle Latour; Isabelle Bézier; Marie Cornic; Angélique Vinit; Céline Monvoisin; Birgit Sawitzki; Simon Leonard; Stéphane Paul; Jean Feuillard; Robin Jeannet; Thomas Daix; Vijay K Tiwari; Jean Marc Tadié; Michel Cogné; Karin Tarte
Journal:  Cell Rep Med       Date:  2021-05-06

5.  Validating and optimizing the method for molecular detection and quantification of SARS-CoV-2 in wastewater.

Authors:  Yuanyuan Qiu; Jiaao Yu; Kanti Pabbaraju; Bonita E Lee; Tiejun Gao; Nicholas J Ashbolt; Steve E Hrudey; Mathew Diggle; Graham Tipples; Rasha Maal-Bared; Xiaoli Pang
Journal:  Sci Total Environ       Date:  2021-11-04       Impact factor: 7.963

6.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

7.  Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.

Authors:  Yongjian Wu; Cheng Guo; Lantian Tang; Zhongsi Hong; Jianhui Zhou; Xin Dong; Huan Yin; Qiang Xiao; Yanping Tang; Xiujuan Qu; Liangjian Kuang; Xiaomin Fang; Nischay Mishra; Jiahai Lu; Hong Shan; Guanmin Jiang; Xi Huang
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-20

8.  Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.

Authors:  Ruofan Wang; Camille R Simoneau; Jessie Kulsuptrakul; Mehdi Bouhaddou; Katherine A Travisano; Jennifer M Hayashi; Jared Carlson-Stevermer; James R Zengel; Christopher M Richards; Parinaz Fozouni; Jennifer Oki; Lauren Rodriguez; Bastian Joehnk; Keith Walcott; Kevin Holden; Anita Sil; Jan E Carette; Nevan J Krogan; Melanie Ott; Andreas S Puschnik
Journal:  Cell       Date:  2020-12-09       Impact factor: 66.850

Review 9.  Wastewater-based epidemiology-surveillance and early detection of waterborne pathogens with a focus on SARS-CoV-2, Cryptosporidium and Giardia.

Authors:  Alireza Zahedi; Paul Monis; Daniel Deere; Una Ryan
Journal:  Parasitol Res       Date:  2021-01-06       Impact factor: 2.383

10.  Elimination of SARS-CoV-2 along wastewater and sludge treatment processes.

Authors:  Albert Serra-Compte; Susana González; Marina Arnaldos; Sabrina Berlendis; Sophie Courtois; Jean Francois Loret; Olivier Schlosser; Adela M Yáñez; Elena Soria-Soria; Mariana Fittipaldi; Gemma Saucedo; Anna Pinar-Méndez; Miquel Paraira; Belén Galofré; Juan M Lema; Sabela Balboa; Miguel Mauricio-Iglesias; Albert Bosch; Rosa M Pintó; Isabelle Bertrand; Christophe Gantzer; Carlos Montero; Xavier Litrico
Journal:  Water Res       Date:  2021-07-15       Impact factor: 11.236

View more
  1 in total

Review 1.  A comprehensive review of various approaches for treatment of tertiary wastewater with emerging contaminants: what do we know?

Authors:  Sasan Zahmatkesh; Awais Bokhari; Melika Karimian; Musaddak Maher Abdul Zahra; Mika Sillanpää; Hitesh Panchal; Ali Jawad Alrubaie; Yousof Rezakhani
Journal:  Environ Monit Assess       Date:  2022-10-14       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.